GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Spring Pharmaceutical Group Inc (OTCPK:CYIG) » Definitions » Growth Rank

Spring Pharmaceutical Group (Spring Pharmaceutical Group) Growth Rank : 0 (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Spring Pharmaceutical Group Growth Rank?

Spring Pharmaceutical Group has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Spring Pharmaceutical Group Growth Rank Related Terms

Thank you for viewing the detailed overview of Spring Pharmaceutical Group's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Spring Pharmaceutical Group (Spring Pharmaceutical Group) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Quanxing Road, Sishui County, Shandong Province, Jinan, CHN, 273200
Spring Pharmaceutical Group Inc is a health care company. The company is engaged in the developing, manufacturing and selling innovative traditional Chinese medicines made from panax ginseng leaves extract, developing acer truncatum bunge planting, processing and selling acer truncatum bunge seed oils in the PRC. Some of its product includes Vitality Source Capsule (24 capsules); Vitality Source Capsules (36 capsules); Millet cattle drinking music and others.